Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MESH : Cholesterol Ester Transfer Proteins"'
Autor:
Eric Bruckert, Ma Feng, Maryam Darabi, Fernando Brites, Marie Lhomme, Eric Frisdal, Wilfried Le Goff, Aurélie Canicio, Lucrèce Matheron, Sandrine Lanfranchi-Lebreton, Alain Carrié, Thierry Huby, Maryse Guerin, Emilie Tubeuf, Carlos Vicente Serrano, Anatol Kontush, Raul D. Santos, Gérard Bolbach, Philippe Couvert, F. Rached, Philippe Lesnik, Maharajah Ponnaiah, Philippe Giral, Isabelle Guillas, Emmanuel L. Gautier
Publikováno v:
European Journal of Preventive Cardiology
European Journal of Preventive Cardiology, Sage Publications, In press, pp.204748731989411. ⟨10.1177/2047487319894114⟩
European Journal of Preventive Cardiology, 2020, 27 (15), pp.1606-1616. ⟨10.1177/2047487319894114⟩
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
European Journal of Preventive Cardiology, Sage Publications, In press, pp.204748731989411. ⟨10.1177/2047487319894114⟩
European Journal of Preventive Cardiology, 2020, 27 (15), pp.1606-1616. ⟨10.1177/2047487319894114⟩
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Background: Low concentrations of high-density lipoprotein cholesterol (HDL-C) represent a well-established cardiovascular risk factor. Paradoxically, extremely high HDL-C levels are equally associated with elevated cardiovascular risk, resulting in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bb2443d1513d6e8186697ac8e2ca25
https://hal.sorbonne-universite.fr/hal-02433564/document
https://hal.sorbonne-universite.fr/hal-02433564/document
Autor:
David Masson, Philippe Gambert, Guillaume Dautin, Laurent Lagrost, J.-P. Pais de Barros, Z. Soltani, Thomas Gautier, Didier Ducloux
Publikováno v:
Kidney International
Kidney International, Nature Publishing Group, 2007, 72 (7), pp.871-8. 〈10.1038/sj.ki.5002449〉
Kidney International, Nature Publishing Group, 2007, 72 (7), pp.871-8. ⟨10.1038/sj.ki.5002449⟩
Kidney International, Nature Publishing Group, 2007, 72 (7), pp.871-8. 〈10.1038/sj.ki.5002449〉
Kidney International, Nature Publishing Group, 2007, 72 (7), pp.871-8. ⟨10.1038/sj.ki.5002449⟩
International audience; Apolipoprotein Cs (apoC-1, apoC-II, and apoC-III) are lipoprotein components that have regulatory effects on enzymes involved in lipoprotein metabolism. Owing to their low molecular weights, apoCs can adsorb onto and/or pass t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a59ec221f77fe60c32d4c64b60e03367
http://www.hal.inserm.fr/inserm-00479730
http://www.hal.inserm.fr/inserm-00479730
Publikováno v:
Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism, Wiley, 2012, 14 (7), pp.662-5. ⟨10.1111/j.1463-1326.2012.01568.x⟩
Diabetes, Obesity and Metabolism, 2012, 14 (7), pp.662-5. ⟨10.1111/j.1463-1326.2012.01568.x⟩
Diabetes, Obesity and Metabolism, Wiley, 2012, 14 (7), pp.662-5. ⟨10.1111/j.1463-1326.2012.01568.x⟩
Diabetes, Obesity and Metabolism, 2012, 14 (7), pp.662-5. ⟨10.1111/j.1463-1326.2012.01568.x⟩
International audience; Dipeptidyl peptidase-4 inhibitors (DPP-4i) improve glycaemic control in type 2 diabetes, but their benefits on reverse cholesterol transport (RCT) remain unknown. We evaluated the effects of DPP-4i sitagliptin 500 mg/kg/day on
Publikováno v:
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2010, 31 (2), pp.149-64. ⟨10.1093/eurheartj/ehp399⟩
European Heart Journal, Oxford University Press (OUP), 2010, 31 (2), pp.149-64. ⟨10.1093/eurheartj/ehp399⟩
European Heart Journal, 2010, 31 (2), pp.149-64. ⟨10.1093/eurheartj/ehp399⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2010, 31 (2), pp.149-64. ⟨10.1093/eurheartj/ehp399⟩
European Heart Journal, Oxford University Press (OUP), 2010, 31 (2), pp.149-64. ⟨10.1093/eurheartj/ehp399⟩
European Heart Journal, 2010, 31 (2), pp.149-64. ⟨10.1093/eurheartj/ehp399⟩
International audience; Subnormal plasma levels of high-density lipoprotein cholesterol (HDL-C) constitute a major cardiovascular risk factor; raising low HDL-C levels may therefore reduce the residual cardiovascular risk that frequently presents in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c598eb5bcf953e99b55e7930364a20b
https://www.hal.inserm.fr/inserm-00581336/document
https://www.hal.inserm.fr/inserm-00581336/document
Autor:
Jean Pierre Amoros, Alessandra Falchi, Ignazio S. Piras, Giuseppe Vona, C. M. Calò, Laurent Varesi, Laurianne Giovannoni
Publikováno v:
Experimental and Molecular Pathology
Experimental and Molecular Pathology, Elsevier, 2007, 83 (1), pp.25-9. ⟨10.1016/j.yexmp.2006.12.007⟩
Experimental and Molecular Pathology, Elsevier, 2007, 83 (1), pp.25-9. ⟨10.1016/j.yexmp.2006.12.007⟩
International audience; The aim of the present study was to investigate the association between coronary artery disease (CAD) and Cholesterol Ester Transfer Protein (CETP) (gaaa)n polymorphisms of the CETP gene in Central Corsica island (France). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91babe5e73708c2dc05cb444168ae8e1
https://hal.archives-ouvertes.fr/hal-00628450
https://hal.archives-ouvertes.fr/hal-00628450